Oncoclínicas do Brasil Serviços Médicos S.A.

B3:ONCO3.SA

5.54 (BRL) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -759.1943.123.3029.59275.439149.33234.9741.22296.94457.047-24.596-15.62515.292150.789-204.888-2.481-123.51614.069-9.327-20.392
Depreciation & Amortization 116.91572.08269.73367.64965.87468.53362.70960.2543.39449.59447.18434.9835.90427.18436.01427.87133.87624.61122.06623.212
Deferred Income Tax 00-26.905-79.544-10.09700000006.1380000000
Stock Based Compensation 5.7745.77510.3235.77411.71113.94813.2647.9211.08212.5325.2895.2862.074-136.764195.4358.418121.176-6.2843.3320
Change In Working Capital 55.7-73.117-298.402-309.168-276.92150.97383.675-362.63747.522-1.61-350.827-208.472-32.2574.809-157.652-32.193-51.126-40.037-5.328-29.592
Accounts Receivables 44.997-127.165-307.802-421.132-255.367-49.57623.92-329.091-354.019-103.562-239.704-107.802-45.636-99.346-44.37-54.519-2.263-32.218-40.666-40.666
Change In Inventory 10.95934.866-16.824-47.848-74.706-1.8821.82912.493-32.088-2.7587.171-42.617-9.079-2.248-9.371-3.52-1.671-11.166-1.17-6.026
Change In Accounts Payables 0071.40758.648-35.40198.26170.246-73.939322.77979.921-108.279-31.86831.63953.413-61.99924.6990000
Other Working Capital -0.25619.182-45.183101.16488.5534.169-132.3227.9110.8524.789-10.015-26.185-9.18152.99-41.9121.147-47.1923.34736.50917.1
Other Non Cash Items 613.241104.27894.572172.641-70.355-59.24-18.6326.499-67.21-100.15674.16111.837-1.43124.93521.5461.974-6.10260.3724.51912.083
Operating Cash Flow 32.436112.138-147.377-133.056-204.349223.546175.986-246.746131.73217.407-248.789-171.99425.7270.953-109.5453.589-25.69252.72935.261-14.689
Investing Activities:
Investments In Property Plant And Equipment -32.83-53.988-105.321-50.801-59.546-116.885-90.997-44.267-65.514-130.25-59.811-48.604-123.867-36.471-21.059-20.548-87.001-8.52-54.641-92.62
Acquisitions Net -229.99800-142-33.0120.013-5.114-8.25-10.379-524.373-48.95-251.661-228.368-174.13200-61.398-22.318-1.4930
Purchases Of Investments 00000000000000000000
Sales Maturities Of Investments 000207.13600118.353478.91900388.632600.46400-0.78347.3270000
Other Investing Activites 419.01185.009-1,716.557-100.746-186.646175.9662.229-2.932-340.06478.911-0.6813.558-1,468.112-0.213-2.827-0.85825.481-43.797-22.708-0.299
Investing Cash Flow 156.18331.021-1,821.878-86.411-279.20459.09424.471423.47-415.957-575.712279.19303.757-1,820.347-210.816-24.66925.921-122.918-74.635-78.841-92.919
Financing Activities:
Debt Repayment -212.274-14.214836.533150.498948.702-65.654-219.518345.11472.684332.799-34.787-91.34741.947-46.85-27.9271.152237.326276.66600
Common Stock Issued 001,500000201.8743.1260.9270-1.7721.77210.3931,779.1640.76208.36000.961
Common Stock Repurchased 030.819-27.234-3.585-0.0174.723-14.973-23.488-5.354-58.408-1.255-13-72.506-50.608-3.979-500-0.049-25.9350
Dividends Paid -1.16-8.142-2.3540-22.535-27.27-9.249-0.659-11.231-1.696-2.795-2.569-20.60301.8-1.8-31.99-13.089-0.069-0.069
Other Financing Activities -46.064-80.842-151.19-65.38-442.493-194.358-17.796-354.11-22.49-102.25-39.026-13.126-101.671-127.272-171.081-26.345-46.402-9.72665.055-20.841
Financing Cash Flow -259.498-72.3792,155.75581.533483.657-282.559-59.662-30.021434.536170.445-79.635-118.263557.561,554.434-200.425-76.851219.213253.80239.052-19.948
Other Information:
Effect Of Forex Changes On Cash 0.2230.0330.312-0.0030.0840.011-0.128-0.154-0.0880.22-0.056-0.4230.3220.101003.402-3.40200
Net Change In Cash -70.65670.813137.82-137.9370.1880.092140.667146.549150.223-387.64-49.2913.077-1,236.6831,414.713-334.639-47.34174.005228.494-4.529-127.556
Cash At End Of Period 550.744621.4550.587412.767550.704550.516550.424409.757263.208112.985500.625549.915536.8381,773.521358.808693.447740.788666.783-4.529319.79